Literature DB >> 11106318

The role of the clinical laboratory in managing chemical or biological terrorism.

S A Jortani1, J W Snyder, R Valdes.   

Abstract

BACKGROUND: Domestic and international acts of terrorism using chemicals and pathogens as weapons have recently attracted much attention because of several hoaxes and real incidents. Clinical laboratories, especially those affiliated with major trauma centers, should be prepared to respond rapidly by providing diagnostic tests for the detection and identification of specific agents, so that specific therapy and victim management can be initiated in a timely manner. As first-line responders, clinical laboratory personnel should become familiar with the various chemical or biological agents and be active participants in their local defense programs. APPROACH: We review the selected agents previously considered or used in chemical and biological warfare, outline their poisonous and pathogenic effects, describe techniques used in their identification, address some of the logistical and technical difficulties in maintaining such tests in clinical laboratories, and comment on some of the analytical issues, such as specimen handling and personal protective equipment. CONTENT: The chemical agents discussed include nerve, blistering, and pulmonary agents and cyanides. Biological agents, including anthrax and smallpox, are also discussed as examples for organisms with potential use in bioterrorism. Available therapies for each agent are outlined to assist clinical laboratory personnel in making intelligent decisions regarding implementation of diagnostic tests as a part of a comprehensive defense program.
SUMMARY: As the civilian medical community prepares for biological and chemical terrorist attacks, improvement in the capabilities of clinical laboratories is essential in supporting counterterrorism programs designed to respond to such attacks. Accurate assessment of resources in clinical laboratories is important because it will provide local authorities with an alternative resource for immediate diagnostic analysis. It is, therefore, recommended that clinical laboratories identify their current resources and the extent of support they can provide, and inform the authorities of their state of readiness.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11106318

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  6 in total

1.  Clinical chemistry through Clinical Chemistry: a journal timeline.

Authors:  Robert Rej
Journal:  Clin Chem       Date:  2004-12       Impact factor: 8.327

2.  Mg-Al-CO3 layered double hydroxide reinforced polymer inclusion membrane as an extractant phase for thin-film microextraction of cyanide from environmental water samples.

Authors:  Maliheh Heidarbeigi; Mohammad Saraji; Mohammad Taghi Jafari
Journal:  Environ Sci Pollut Res Int       Date:  2019-07-24       Impact factor: 4.223

3.  Rapid point of care analyzer for the measurement of cyanide in blood.

Authors:  Jian Ma; Shin-Ichi Ohira; Santosh K Mishra; Mahitti Puanngam; Purnendu K Dasgupta; Sari B Mahon; Matthew Brenner; William Blackledge; Gerry R Boss
Journal:  Anal Chem       Date:  2011-05-10       Impact factor: 6.986

Review 4.  Ophthalmological aspects of mustard gas poisoning (focus on management).

Authors:  Mehrdad Rafati-Rahimzadeh; Mehravar Rafati-Rahimzadeh; Sohrab Kazemi; Seyedeh Roghieh Jafarian Amiri; Abbas Soleymani; Ali Akbar Moghadamnia
Journal:  Caspian J Intern Med       Date:  2022

5.  Analysis of Bio-Risk Management System Implementation in Indonesian Higher Education Laboratory.

Authors:  Anom Bowolaksono; Fatma Lestari; Saraswati Andani Satyawardhani; Abdul Kadir; Cynthia Febrina Maharani; Debby Paramitasari
Journal:  Int J Environ Res Public Health       Date:  2021-05-11       Impact factor: 3.390

6.  Multi-pathogens sequence containing plasmids as positive controls for universal detection of potential agents of bioterrorism.

Authors:  Remy N Charrel; Bernard La Scola; Didier Raoult
Journal:  BMC Microbiol       Date:  2004-05-17       Impact factor: 3.605

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.